Medifast (MED) Operating Expenses (2010 - 2026)

Medifast has reported Operating Expenses for 17 years, with the latest figure at $55.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 35.62% year-over-year to $55.1 million; the trailing twelve-month figure through Mar 2026 stood at $258.9 million (down 36.52% YoY), and the FY2025 full-year result was $289.4 million, down 34.49% from the prior year.
• Operating Expenses for Q1 2026 stood at $55.1 million, down from $59.9 million in the prior quarter.
• The five-year high for Operating Expenses was $272.7 million in Q2 2022, with the low at $55.1 million in Q1 2026.
• Historically, Operating Expenses has averaged $140.7 million across 5 years, with a median of $131.3 million in 2024.
• Annual changes were most pronounced in 2022 — Operating Expenses climbed 26.28% — and 2025, when it tumbled 40.82%.
• Medifast's Operating Expenses stood at $201.0 million in 2022, then tumbled by 33.98% to $132.7 million in 2023, then sank by 34.05% to $87.5 million in 2024, then sank by 31.5% to $59.9 million in 2025, then declined by 8.16% to $55.1 million in 2026.
• The last three Operating Expenses figures came in at $55.1 million (Q1 2026), $59.9 million (Q4 2025), and $66.2 million (Q3 2025), per Business Quant data.